Cryo-Cell International, Inc. Watch

from 8-K 11 pages Second Amended and Restated Promissory Note

from 8-K 10 pages Second Amendment to Credit Agreement

from 8-K 80 pages Asset Purchase Agreement

from 8-K 14 pages Stock Purchase Agreement

from 8-K 3 pages Amendment No. 1 to Asset Purchase Agreement

from 8-K 25 pages Asset Purchase Agreement by and Between Cytomedical Design Group LLC as Seller, and Cryo-Cell International, Inc., as Purchaser June 15, 2015

from SC 13D/A 32 pages As of the Date of This Notice, the Record Holder Represents That He Is the Record Owner of 100 Shares of Common Stock, Par Value $0.01 Per Share (The “Common Stock”), of the Company and That He Is Entitled to Vote at the Annual Meeting. the Record Holder May Be Deemed the Beneficial Owner of 660,251 Shares of Common Stock in Addition to the 100 Shares Held of Record by Him. Specifically, as Chairman of the Board of Directors and Secretary of Partnercommunity, Inc. (“Partnercommunity”), a Shareholder of Record of the Common Stock, the Record Holder May Be Deemed to Be the Beneficial Owner of Such Shares Held by Partnercommunity. Additionally, the Record Holder, as Managing Member of Mayim Management, LLC (“Mayim”), Which May Exercise Investment and Voting Discretion Over Partnercommunity’s Shares of the Common Stock Under the Investment Advisory Agreement (As Defined Below), Pursuant to the Information Provided in Annex A, May Be Deemed to Beneficially Own Shares of Common Stock Held of Record by Mayim. Finally, the Record Holder May Be Deemed the Beneficial Owner of Additional Shares of the Common Stock as Set Forth in Attachment 1 of Annex A